Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Segmental resection for bronchogenic carcinoma.

R J Jensik, L P Faber, C F Kittle

    The Annals of Thoracic Surgery
    |November 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A multi-analyte serum test for the detection of non-small cell lung cancer.

    British journal of cancer·2010
    Same author

    Patent omphalomesenteric duct and its relation to the diverticulum of Meckel.

    Archives of surgery (Chicago, Ill. : 1920)·2010
    Same author

    Esophageal leiomyoma; report of a successful resection.

    Journal of the American Medical Association·2010
    Same author

    The Influence of an Activated Sterol on Blood Pressure in Dogs.

    The American journal of pathology·2009
    Same author

    Modulation of tumor-infiltrating lymphocyte cytolytic activity against human non-small cell lung cancer.

    Lung cancer (Amsterdam, Netherlands)·2002
    Same author

    The history of lobectomy and segmentectomy including sleeve resection.

    Chest surgery clinics of North America·2000
    Same journal

    Does prior percutaneous coronary revascularization negatively affect the outcomes of subsequent coronary artery bypass grafting?

    The Annals of thoracic surgery·2026
    Same journal

    Lymph Node Dissection and Chylothorax - Balancing Oncologic Benefit Against Morbidity.

    The Annals of thoracic surgery·2026
    Same journal

    Preserved Antegrade Pulmonary Blood Flow in Bidirectional Glenn: Outcomes and Considerations for Staged Palliation.

    The Annals of thoracic surgery·2026
    Same journal

    Domo Arigato, Mr. Roboto.

    The Annals of thoracic surgery·2026
    Same journal

    Impact of High SUVmax on Recurrence by Resection Strategy in Stage IA Adenocarcinoma ≤2 cm.

    The Annals of thoracic surgery·2026
    Same journal

    Preoperative Treatment for Stage II NSCLC Requires Multidimensional Consideration.

    The Annals of thoracic surgery·2026
    See all related articles

    Segmental resection for early-stage lung cancer shows a 53% 5-year survival rate. Epidermoid bronchogenic carcinoma offers the most favorable prognosis in this surgical approach.

    Area of Science:

    • Thoracic Surgery
    • Surgical Oncology
    • Pulmonary Medicine

    Background:

    • Segmental resection is a surgical option for peripheral, Stage I bronchogenic carcinoma.
    • Understanding the outcomes of this procedure is crucial for treatment planning.

    Purpose of the Study:

    • To evaluate the efficacy and outcomes of segmental resection for Stage I lung cancer.
    • To analyze survival rates and complications associated with this surgical approach.

    Main Methods:

    • A retrospective review of 168 patients undergoing segmental resection for peripheral, Stage I bronchogenic carcinoma between 1957 and 1978.
    • Analysis of tumor types, resection locations, surgical mortality, complications, and long-term survival.

    Main Results:

    Related Experiment Videos

    • The most common tumor types were adenocarcinoma (44%) and epidermoid (34%).
    • Surgical mortality was low (<2%), with air leak being the most frequent complication (6%).
    • Actuarial survival rates were 53% at 5 years, 33% at 10 years, and 25% at 15 years. Patients with epidermoid lesions demonstrated the best prognosis.

    Conclusions:

    • Segmental resection is a viable surgical option for select patients with early-stage lung cancer, offering acceptable mortality and complication rates.
    • Long-term survival is achievable, with significant differences noted based on tumor histology, favoring epidermoid types.